Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$237.84 USD

237.84
1,019,640

+0.54 (0.23%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $237.77 -0.07 (-0.03%) 7:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Becton, Dickinson (BDX) Q2 Earnings: What's in the Cards?

Becton, Dickinson's (BDX) second-quarter performance faces risks from unfavorable foreign exchange rate.

    AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint?

    AmerisourceBergen's (ABC) third-quarter performance face risks from reduced contract renewals and lower generic inflation.

      Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?

      The timing of Good Friday is likely to dampen sales at Henry Schein (HSIC) in second-quarter 2017. Meanwhile, geographic expansion should continue.

        McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

        McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

          What's in Store for Express Scripts (ESRX) in Q2 Earnings?

          Despite an upbeat guidance, cutthroat competition in the niche space is likely to mar Express Scripts' (ESRX) growth in the second quarter.

            GNC Holdings (GNC) Q2 Earnings: Disappointment in the Cards?

            We do not expect GNC Holdings (GNC) to beat estimates in Q2 earnings on account of a tough competitive landscape and currency headwinds.

              MedTech Thriving on Consolidation & Expansion: Stocks to Buy

              The industry has some powerful long-term tailwinds of the medical device industry like mergers & acquisitions (M&A), emerging market expansion, positive demographic trends and new product innovation.

                Mark Vickery headshot

                Top Analyst Reports for Procter & Gamble, Verizon & Citigroup

                Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon (VZ) and Citigroup (C).

                  Why Is Becton, Dickinson (BDX) Up 3% Since the Last Earnings Report?

                  Becton, Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                    Mark Vickery headshot

                    Top Research Reports for May 4, 2017

                    Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil (XOM), JPMorgan (JPM) and Union Pacific (UNP).

                      Becton, Dickinson (BDX) Beats On Earnings & Revenues In Q2

                      Becton, Dickinson's adjusted earnings of $2.30 per share beat the Zacks Consensus Estimate by 7 cents and increased 5.5% from $2.18 posted in the year-ago quarter.

                        Medical Product Q1 Earnings Due on May 2: BDX, DXCM & More

                        The medical product sector shines bright at the moment owing to the prevalence of minimally invasive surgeries, liquid biopsy tests, and use of IT for ensuring quick and improved patient care among other things.

                          Is a Surprise Coming for Becton (BDX) This Earnings Season?

                          Becton (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                            Can CVS Health (CVS) Spring a Surprise this Earnings Season?

                            CVS Health Corporation (CVS) is scheduled to report its first-quarter 2017 results before the opening bell on May 2.

                              Will LabCorp (LH) Pull a Surprise this Earnings Season?

                              Laboratory Corp. of America Holdings (LH) or LabCorp is expected to report first-quarter 2017 results before the market opens on Apr 25.

                                Becton, Dickinson and Company (BDX) Up 3.8% Since Earnings Report: Can It Continue?

                                Becton, Dickinson and Company (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  Mark Vickery headshot

                                  Top Research Reports for March 3, 2017

                                  Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Caterpillar (CAT) and Broadcom (AVGO).

                                    Becton, Dickinson Launches BD Resolve Early Access Program

                                    Leading global medical technology company, Becton, Dickinson and Company (BDX), popularly known as BD, recently announced an early access program for the BD Resolve Single-Cell Gene Expression platform.

                                      Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues

                                      Becton, Dickinson and Company (BDX) reported first-quarter fiscal 2017 earnings of $2.33 per share, which beat the Zacks Consensus Estimate by 22 cents and increased from $1.96 posted in the year-ago quarter.

                                        Becton, Dickinson (BDX) Beats Q1 Earnings & Revenues

                                        Becton, Dickinson???s adjusted earnings of $2.33 per share beat the Zacks Consensus Estimate by 22 cents.

                                          Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?

                                          Becton, Dickinson and Company (BDX) is set to report first-quarter fiscal 2017 earnings results on Feb 2.

                                            Becton, Dickinson Commercially Launches Precise WTA Kits

                                            Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has made its Precise whole transcriptome analysis kits commercial available.

                                              Sheraz Mian headshot

                                              Top 4 Research Reports for August 11, 2016

                                              Today's must-read reports are for Priceline (PCLN), Time Warner (TWX), Public Storage (PSA) and Southern Company (SO).

                                                3 Medical Devices Stocks Set to Beat this Earnings Season

                                                The stupendous first-quarter performance by the Medical sector is something investors definitely need to muse on.